Stock Analysis

Lindian Resources and Core Lithium joined the S&P/ASX 300 on 21 September, but both have spent parts of September giving back ground. Lindian has slipped well below its August levels as investors weigh execution risk in Malawi, while Core Lithium's pullback looks more like …

For Mineral Resources, the next chapter depends on whether the lithium price recovery holds up after its promotion to the S&P/ASX 50. For Vulcan Energy, it depends on building its funded German lithium project and winning back investors who have pushed the shares to …

Interest rates, fundraising momentum and the health of Australia's property and credit markets are likely to shape the outlook for HMC Capital and Qualitas. Both reported growth in FY26 and guided to more in FY27, but a looming RBA decision and a jitteryBond Marketmean …

Netwealth and HUB24 are sliding together because investors are questioning the pace of future fund flows and profit margins, not the platforms' recent results. Rising interest rates, softer flows in some account types and, for Netwealth, fresh legal and deal news have added to …

Mayne Pharma and Orthocell are both small-cap healthcare companies trading well below their highs. Their next moves are likely to depend on very different things. For Mayne, the question is what the board does next after itsTakeovercollapsed, and how the Cosette litigation ends. For …

Egg producer Farm Pride Foods and seaweed feed-additive company Sea Forest are both small consumer staples stocks, but different forces will shape their returns against the S&P/ASX 200. For Farm Pride, the drivers are egg prices, biosecurity and itsCapitalspending. For Sea Forest, they are …

Generation Development and CenturiaCapitalare both losing ground because their August results showed that strong growth in funds under management will not quickly lift earnings per share. For GDG the issue is fast-rising costs and dilution from its Evidentia deal. For Centuria it is a …